Brain conditions, mental and neurological alike
Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
A vision of a world free from the effects of multiple sclerosis
Dr Katie Howe, Research Communications Manager at the MS Society charts a vision of a world free from the effects of multiple sclerosis.
Dementia research in the UK and COVID-19
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
How to fight diabetes with improved body composition
Here the InBody Clinical Team explain how improved body composition can help fight type 2 diabetes.
Dementia Tech: Overcoming barriers to innovation post-pandemic
Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
Diagnosis of dementia: The impact of COVID-19
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
ICE detention centres withheld vaccines from child migrants
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
Why do people with dementia often go missing?
New research by the University of East Anglia found that 70% of people with dementia go missing - but why?
Long haul COVID-19 survivors experience lasting skin problems
According to a new analysis, COVID-19 patients have shown lasting skin problems long after their initial infection has cleared.
The ‘herd immunity’ strategy for COVID-19 is dangerous and unfeasible
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Introduction to E.coli and diarrheal disease
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill provides an informative introduction to E. coli and diarrheal disease.
COVID-19 and diabetes: What do we (not) know?
Dr Lucy Chambers, Head of Research Communications at Diabetes UK, provides us with her thoughts on COVID-19 and diabetes, in terms of what do we (not) know.
Innovative treatments for heart failure
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
Importance of choice: Insulin delivery systems for Type 1 diabetes in the UK (Advertorial)
Hjalte Hojsgaard, Insulet International, highlights why choice of insulin delivery devices is important, and why access to this life-changing technology is not yet fully utilised in UK diabetes services.
The evolution of healthcare: How can telehealth ease diabetes management?
Digital health company Glooko sees a paradigm shift in healthcare with increased remote monitoring and easier access to telehealth.
Diabetes: Innovative technology for long-term health conditions
Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.
The relationship between diabetes and muscle mass
InBody Clinical Team describes the relationship between diabetes, one of the most common diseases of the modern age, and muscle mass.
Reducing the burden of diabetes management through flexible and discreet insulin delivery
Alex Evans, UK Country Manager for ViCentra B.V., discusses how insulin pump system Kaleido can provide solutions to reduce the practical and emotional burden of living with diabetes.
Alzheimer’s disease: Incurable but preventable?
Jonathan Baker of, GBS Clinic, sheds light on the current extent of our knowledge of Alzheimer’s disease.
Eye health: Diabetic Retinal Screening
Max Halford FBDO CL, Clinical Lead for the Association of British Dispensing Opticians, tells us what we need to know about Diabetic Retinal Screening in this eye health focus.
